Edition:
United States

Precipio Inc (PRPO.OQ)

PRPO.OQ on NASDAQ Stock Exchange Capital Market

0.71USD
16 Feb 2018
Change (% chg)

$-0.01 (-1.57%)
Prev Close
$0.72
Open
$0.73
Day's High
$0.75
Day's Low
$0.70
Volume
15,869
Avg. Vol
12,038
52-wk High
$28.16
52-wk Low
$0.68

Latest Key Developments (Source: Significant Developments)

Precipio Reports Q4 Revenue $945,000
Friday, 9 Feb 2018 09:00am EST 

Feb 9 (Reuters) - Precipio Inc ::PRECIPIO ANNOUNCES Q4 2017 REVENUE AT 350% OF PREVIOUS QUARTER.Q4 REVENUE $945,000 VERSUS $316,000.  Full Article

Precipio Q3 sales fell 26 percent
Monday, 20 Nov 2017 04:05pm EST 

Nov 20 (Reuters) - Precipio Inc :Precipio announces third quarter 2017 financial results and provides corporate update.Q3 sales fell 26 percent.Precipio Inc - qtrly loss per common share $1.36​.  Full Article

Precipio appoints Samuel Riccitelli as Chairman, David Cohen as director
Tuesday, 14 Nov 2017 04:15pm EST 

Nov 14 (Reuters) - Precipio Inc :Precipio appoints Samuel D. Riccitelli as Chairman of the Board of Directors and elects David Cohen as director.Precipio Inc - ‍ Riccitelli replaces Robert Patzig​.  Full Article

Transgenomic prepares for planned relisting on NASDAQ
Wednesday, 21 Jun 2017 07:30am EDT 

June 21 (Reuters) - Transgenomic Inc ::Transgenomic Inc - is advancing its previously announced plans for relisting on Nasdaq capital market.  Full Article

Transgenomic and Precipio Diagnostics announce planned merger
Wednesday, 12 Oct 2016 10:30pm EDT 

Transgenomic Inc : Transgenomic and precipio diagnostics announce planned merger . Says has filed to complete a reverse stock split of between one-for-ten and one-for-thirty before merger closes . Anticipated that original precipio security holders will receive between 62% and 80% of outstanding shares of combined co .Says company's outstanding debt is expected to convert into common and preferred shares.  Full Article

Transgenomic and Ventana Medical signs data sharing agreement
Thursday, 22 Sep 2016 08:11am EDT 

Transgenomic Inc :Says signed data sharing agreement with Ventana Medical Systems Inc, a subsidiary of Roche Holdings.  Full Article

Transgenomic says Q2 loss per share $0.10 from cont ops
Friday, 12 Aug 2016 04:05pm EDT 

Transgenomic Inc : Transgenomic reports second quarter 2016 financial results .Q2 loss per share $0.10 from continuing operations.  Full Article

Transgenomic reports Q1 loss per share of $0.10 from continuing operations
Tuesday, 24 May 2016 07:00am EDT 

Transgenomic Inc : Transgenomic reports first quarter 2016 financial results .Q1 loss per share $0.10 from continuing operations.  Full Article

BRIEF-Precipio Launches Unique Lung Cancer Monitoring Test For Therapy Resistance

* PRECIPIO LAUNCHES UNIQUE LUNG CANCER MONITORING TEST FOR THERAPY RESISTANCE